Scientific Brainstorming
Purpose and boundaries
Use this skill to create, organize, challenge, and transparently prioritize
candidate research directions. Treat every output as a proposal, not a
finding. Creativity methods can alter participation and idea yield, but no
method universally improves originality, usefulness, or scientific validity.
The evidence base and its limits are summarized in
references/sources.md.
Keep these activities separate:
- Ideation creates questions, mechanisms, alternatives, or study concepts.
- Evidence assessment checks what reliable literature and data support.
- Hypothesis validation requires observations, predictions, suitable
designs, analyses, and independent scrutiny; brainstorming cannot validate a
hypothesis.
- Ethics, biosafety, dual-use, regulatory, and institutional review require
the relevant authorized reviewers. A brainstorm is never approval.
- Clinical advice requires qualified clinicians and patient-specific
context. Do not turn research ideas into diagnosis or treatment guidance.
For an observation-led testable hypothesis, hand off to
hypothesis-generation. For study architecture, use experimental-design;
for sample size, statistical-power; for existing evidence,
literature-review; and for analysis, statistical-analysis.
Operating rules
- Label claims as idea, assumption, prediction, located
evidence, or decision. Never blur these categories.
- Generate independently before exposing participants to other people's or
AI-generated ideas. Face-to-face turn-taking can block production, and
examples can anchor later output.
- Preserve minority views, negative evidence, uncertainty, and abstentions.
Consensus is not truth and vote counts are not effect sizes.
- Record provenance without exposing confidential, personal, controlled, or
unpublished information.
- Define evaluation criteria and directions before scoring. Keep raw ratings,
reasons, ranges, and disagreement visible.
- Search the literature after an initial independent round when practical,
then deliberately reopen ideation. This reduces early anchoring without
mistaking an incomplete search for a research gap.
- Do not automatically select a “winner.” Scores are traceable decision aids;
qualitative judgment, uncertainty, feasibility, and ethics gates remain
controlling.
Reproducible workflow
1. Scope the session
Write one focal question and record:
- purpose, audience, decision owner, and time horizon;
- in-scope and out-of-scope topics;
- constraints that are real, assumed, negotiable, or unknown;
- current knowledge, unresolved observations, and prohibited outputs;
- whether human participants, animals, clinical care, sensitive data,
pathogens, controlled technologies, or environmental release could be
implicated.
If the request seeks patient-specific care, evasion of oversight, harmful
optimization, or operationally enabling dual-use details, stop ideation and
route to the appropriate professional or institutional process.
2. Diversify perspectives deliberately
Invite relevant methodological, domain, implementation, statistical, safety,
ethics, stakeholder, and lived-experience perspectives. Diversity is not a
guarantee of creativity: explain whose perspective is represented, missing, or
structurally disadvantaged. Use accessible participation modes and
pseudonymous participant IDs where appropriate.
The facilitator should disclose conflicts, avoid offering a preferred answer
first, prevent senior members from dominating, and ask leaders to contribute
after the independent round.
3. Generate independently
Give everyone the same neutral prompt, constraints, and fixed time window.
Participants write ideas privately and in parallel before discussion. For each
idea, capture:
- a stable ID and one-sentence statement;
- contributor ID(s) and stage (
independent, discussion, or post-check);
- origin (
human, AI-assisted, literature-inspired, mixed, or other);
- assumptions, predicted observations, uncertainties, and possible
disconfirming evidence;
- source identifiers for literature-inspired ideas and tool/purpose disclosure
for AI assistance.
Do not show example solutions before this round unless examples are necessary;
if they are, record them as potential anchors.
4. Share without immediate evaluation
Use round-robin or pooled silent sharing. Clarify wording without advocacy.
Permit a private or anonymous channel. Ask each participant what is missing,
what contradicts the dominant framing, and which idea became less obvious
after hearing the group.
5. Cluster structurally
Group ideas by an explicit relation such as shared outcome, mechanism,
population, scale, or method. Keep original IDs and text. Record merges and
splits. Similar wording is not proof of semantic equivalence; retain distinct
ideas when their assumptions, intervention, population, or predictions differ.
See references/facilitation_workflows.md.
6. Define transparent criteria
Before rating, define each criterion, direction, scale anchors, evidence
needed, conflicts, and explicit weights. Common dimensions include:
- potential information gain and discriminating predictions;
- relevance to the scoped question;
- originality relative to the checked literature, not merely to the room;
- feasibility, resources, and reversibility;
- methodological rigor and vulnerability to bias;
- ethics, safety, equity, dual-use, and regulatory burden;
- value if the result is null or contradicts the favored mechanism.
Use ranges or confidence labels where assessors are uncertain. Do not hide
vetoes inside an averaged score. See references/idea_evaluation.md.
7. Run adversarial review
Assign a reviewer who did not originate each shortlisted idea. Ask:
- What observation would make this idea wrong or uninformative?
- Which alternative explanation fits the same predicted result?
- What hidden dependency, measurement failure, confounder, or selection effect
could dominate?
- Are authority, anchoring, group loyalty, publication incentives, or an
attractive technology driving preference?
- Could this cause harm, worsen inequity, expose sensitive information, or
enable misuse?
Record the response, mitigation, residual uncertainty, and whether the idea was
revised—not just pass/fail.
8. Check literature and evidence
Search authoritative databases, primary studies, methods guidance, negative
results, and adjacent fields. Verify every citation at its source. For each
idea, record query/date, sources screened, evidence for and against, and search
limits. Use statuses such as not-checked, search-incomplete,
support-located, challenge-located, or mixed.
Absence from a bounded search does not establish novelty, and supportive
literature does not validate a new mechanism. Reopen one short independent
generation round after the evidence check.
9. Apply feasibility, rigor, and ethics gates
Before advancing an idea, identify the appropriate domain review:
- For biomedical work, consider rigor of prior research, robust design,
relevant biological variables, and resource authentication. When NIH policy
applies, sex as a biological variable should be considered from the research
question through design, analysis, and reporting; justify a single-sex scope
with relevant evidence.
- Route human-subjects, animal, biosafety, data-governance, export-control,
clinical, environmental, and other regulated work to the relevant office.
- Screen life-science and enabling-technology ideas for dual-use or misuse
potential early. Current U.S. oversight is evolving; consult the institution
and current agency policy rather than relying on a static checklist.
- Do not upload sensitive, unpublished, proprietary, controlled, or personal
information to an external AI service.
An ethics or feasibility concern may require redesign, controlled handling, or
stopping. A high creativity score never overrides a gate.
10. Decide and log
The accountable human decision owner records:
- candidates considered and criteria/weights used;
- raw ratings, uncertainty ranges, dissent, abstentions, and sensitivity
results;
- literature and review dates;
- gate outcomes and required approvals;
- decision, rationale, rejected alternatives, unresolved risks, owner, and
revisit trigger.
Label the next action correctly: further search, consultation, simulation,
pilot design, protocol development, preregistration, or no action. If a
confirmatory study is planned, preregister hypotheses and analysis decisions
before outcomes are known; report later deviations and exploratory work
transparently. Preregistration improves transparency but is not peer review,
ethical approval, or proof of validity.
Bias and failure controls
- Production blocking: private parallel generation before oral discussion.
- Anchoring and design fixation: no leader answer or AI examples until the
independent round; reopen generation after evidence review.
- Authority and status effects: leader-last sharing, anonymous input,
independent ratings, and visible dissent.
- Groupthink: assign a genuine alternative-generation role, invite outside
review, and document rejected options. Treat “groupthink” as a family of
risks, not a single universally established diagnosis.
- Evaluation apprehension: separate contribution from attribution where
possible; critique ideas, not contributors.
- Premature convergence: fixed divergence window followed by an explicit
transition and predeclared criteria.
- False precision: use anchored scales, uncertainty ranges, sensitivity
analysis, and narrative review.
- Research-gap inflation: record search boundaries and use “no direct
evidence located,” not “never studied.”
- AI hallucination or homogenization: human-first ideation, provenance,
independent verification, multiple non-AI perspectives, and comparison for
suspiciously repeated frames. See
references/responsible_ai.md.
Optional local CLIs
The scripts are deterministic, standard-library utilities. They do not call a
network service, LLM, or scientific database and do not make scientific
conclusions.
python scripts/session_scaffold.py --help
python scripts/validate_register.py --help
python scripts/evaluate_matrix.py --help
Create a session register:
python scripts/session_scaffold.py \
--session-id "microbiome-01" \
--title "Microbiome mechanism ideation" \
--question "Which mechanisms could explain the scoped observation?" \
--participant P01 --participant P02 \
--output session.json
Validate structure and provenance:
python scripts/validate_register.py session.json --output validation.json
Calculate a fully disclosed weighted matrix from CSV, including score intervals
and one-at-a-time weight sensitivity:
python scripts/evaluate_matrix.py scores.csv \
--config criteria.json \
--weight-delta 0.10 \
--output matrix.json
Outputs refuse symlinks and existing files unless --force is explicit; inputs
and collection sizes are bounded. The validator checks structure, not truth.
The matrix preserves qualitative review and uncertainty and leaves
decision null. Input formats and interpretation are documented in
references/idea_evaluation.md.
Reference index
references/brainstorming_methods.md — evidence-calibrated method selection,
nominal groups, Delphi, structured elicitation, and creative prompts.
references/facilitation_workflows.md — ready-to-run individual, group, and
asynchronous session protocols plus provenance templates.
references/idea_evaluation.md — criteria, scoring formula, uncertainty,
sensitivity analysis, gates, and decision logs.
references/responsible_ai.md — accountable AI assistance, confidentiality,
hallucination, homogenization, disclosure, dual-use, and integrity.
references/sources.md — dated primary studies and official guidance
consulted for this version.
1---
2name: scientific-brainstorming
3description: Facilitates evidence-aware scientific ideation with independent generation, structured discussion, explicit assumptions, transparent evaluation, adversarial review, and decision logs. Use for early-stage research brainstorming or prioritizing candidate directions; hand off empirical validation, study design, ethics or regulatory review, and clinical questions to appropriate experts or skills.
4license: MIT
5compatibility: Core guidance works in any Agent Skills-compatible host. Optional bundled CLIs require Python 3.11+ and use only the standard library; they make no network or LLM calls and require no credentials.
6metadata:
7 version: "1.1"
8 skill-author: "K-Dense Inc."
9---
10
11# Scientific Brainstorming
12
13## Purpose and boundaries
14
15Use this skill to create, organize, challenge, and transparently prioritize
16candidate research directions. Treat every output as a **proposal**, not a
17finding. Creativity methods can alter participation and idea yield, but no
18method universally improves originality, usefulness, or scientific validity.
19The evidence base and its limits are summarized in
20`references/sources.md`.
21
22Keep these activities separate:
23
24- **Ideation** creates questions, mechanisms, alternatives, or study concepts.
25- **Evidence assessment** checks what reliable literature and data support.
26- **Hypothesis validation** requires observations, predictions, suitable
27 designs, analyses, and independent scrutiny; brainstorming cannot validate a
28 hypothesis.
29- **Ethics, biosafety, dual-use, regulatory, and institutional review** require
30 the relevant authorized reviewers. A brainstorm is never approval.
31- **Clinical advice** requires qualified clinicians and patient-specific
32 context. Do not turn research ideas into diagnosis or treatment guidance.
33
34For an observation-led testable hypothesis, hand off to
35`hypothesis-generation`. For study architecture, use `experimental-design`;
36for sample size, `statistical-power`; for existing evidence,
37`literature-review`; and for analysis, `statistical-analysis`.
38
39## Operating rules
40
411. Label claims as **idea**, **assumption**, **prediction**, **located
42 evidence**, or **decision**. Never blur these categories.
432. Generate independently before exposing participants to other people's or
44 AI-generated ideas. Face-to-face turn-taking can block production, and
45 examples can anchor later output.
463. Preserve minority views, negative evidence, uncertainty, and abstentions.
47 Consensus is not truth and vote counts are not effect sizes.
484. Record provenance without exposing confidential, personal, controlled, or
49 unpublished information.
505. Define evaluation criteria and directions before scoring. Keep raw ratings,
51 reasons, ranges, and disagreement visible.
526. Search the literature **after an initial independent round** when practical,
53 then deliberately reopen ideation. This reduces early anchoring without
54 mistaking an incomplete search for a research gap.
557. Do not automatically select a “winner.” Scores are traceable decision aids;
56 qualitative judgment, uncertainty, feasibility, and ethics gates remain
57 controlling.
58
59## Reproducible workflow
60
61### 1. Scope the session
62
63Write one focal question and record:
64
65- purpose, audience, decision owner, and time horizon;
66- in-scope and out-of-scope topics;
67- constraints that are real, assumed, negotiable, or unknown;
68- current knowledge, unresolved observations, and prohibited outputs;
69- whether human participants, animals, clinical care, sensitive data,
70 pathogens, controlled technologies, or environmental release could be
71 implicated.
72
73If the request seeks patient-specific care, evasion of oversight, harmful
74optimization, or operationally enabling dual-use details, stop ideation and
75route to the appropriate professional or institutional process.
76
77### 2. Diversify perspectives deliberately
78
79Invite relevant methodological, domain, implementation, statistical, safety,
80ethics, stakeholder, and lived-experience perspectives. Diversity is not a
81guarantee of creativity: explain whose perspective is represented, missing, or
82structurally disadvantaged. Use accessible participation modes and
83pseudonymous participant IDs where appropriate.
84
85The facilitator should disclose conflicts, avoid offering a preferred answer
86first, prevent senior members from dominating, and ask leaders to contribute
87after the independent round.
88
89### 3. Generate independently
90
91Give everyone the same neutral prompt, constraints, and fixed time window.
92Participants write ideas privately and in parallel before discussion. For each
93idea, capture:
94
95- a stable ID and one-sentence statement;
96- contributor ID(s) and stage (`independent`, `discussion`, or `post-check`);
97- origin (`human`, `AI-assisted`, `literature-inspired`, `mixed`, or `other`);
98- assumptions, predicted observations, uncertainties, and possible
99 disconfirming evidence;
100- source identifiers for literature-inspired ideas and tool/purpose disclosure
101 for AI assistance.
102
103Do not show example solutions before this round unless examples are necessary;
104if they are, record them as potential anchors.
105
106### 4. Share without immediate evaluation
107
108Use round-robin or pooled silent sharing. Clarify wording without advocacy.
109Permit a private or anonymous channel. Ask each participant what is missing,
110what contradicts the dominant framing, and which idea became less obvious
111after hearing the group.
112
113### 5. Cluster structurally
114
115Group ideas by an explicit relation such as shared outcome, mechanism,
116population, scale, or method. Keep original IDs and text. Record merges and
117splits. Similar wording is not proof of semantic equivalence; retain distinct
118ideas when their assumptions, intervention, population, or predictions differ.
119See `references/facilitation_workflows.md`.
120
121### 6. Define transparent criteria
122
123Before rating, define each criterion, direction, scale anchors, evidence
124needed, conflicts, and explicit weights. Common dimensions include:
125
126- potential information gain and discriminating predictions;
127- relevance to the scoped question;
128- originality relative to the checked literature, not merely to the room;
129- feasibility, resources, and reversibility;
130- methodological rigor and vulnerability to bias;
131- ethics, safety, equity, dual-use, and regulatory burden;
132- value if the result is null or contradicts the favored mechanism.
133
134Use ranges or confidence labels where assessors are uncertain. Do not hide
135vetoes inside an averaged score. See `references/idea_evaluation.md`.
136
137### 7. Run adversarial review
138
139Assign a reviewer who did not originate each shortlisted idea. Ask:
140
141- What observation would make this idea wrong or uninformative?
142- Which alternative explanation fits the same predicted result?
143- What hidden dependency, measurement failure, confounder, or selection effect
144 could dominate?
145- Are authority, anchoring, group loyalty, publication incentives, or an
146 attractive technology driving preference?
147- Could this cause harm, worsen inequity, expose sensitive information, or
148 enable misuse?
149
150Record the response, mitigation, residual uncertainty, and whether the idea was
151revised—not just pass/fail.
152
153### 8. Check literature and evidence
154
155Search authoritative databases, primary studies, methods guidance, negative
156results, and adjacent fields. Verify every citation at its source. For each
157idea, record query/date, sources screened, evidence for and against, and search
158limits. Use statuses such as `not-checked`, `search-incomplete`,
159`support-located`, `challenge-located`, or `mixed`.
160
161Absence from a bounded search does not establish novelty, and supportive
162literature does not validate a new mechanism. Reopen one short independent
163generation round after the evidence check.
164
165### 9. Apply feasibility, rigor, and ethics gates
166
167Before advancing an idea, identify the appropriate domain review:
168
169- For biomedical work, consider rigor of prior research, robust design,
170 relevant biological variables, and resource authentication. When NIH policy
171 applies, sex as a biological variable should be considered from the research
172 question through design, analysis, and reporting; justify a single-sex scope
173 with relevant evidence.
174- Route human-subjects, animal, biosafety, data-governance, export-control,
175 clinical, environmental, and other regulated work to the relevant office.
176- Screen life-science and enabling-technology ideas for dual-use or misuse
177 potential early. Current U.S. oversight is evolving; consult the institution
178 and current agency policy rather than relying on a static checklist.
179- Do not upload sensitive, unpublished, proprietary, controlled, or personal
180 information to an external AI service.
181
182An ethics or feasibility concern may require redesign, controlled handling, or
183stopping. A high creativity score never overrides a gate.
184
185### 10. Decide and log
186
187The accountable human decision owner records:
188
189- candidates considered and criteria/weights used;
190- raw ratings, uncertainty ranges, dissent, abstentions, and sensitivity
191 results;
192- literature and review dates;
193- gate outcomes and required approvals;
194- decision, rationale, rejected alternatives, unresolved risks, owner, and
195 revisit trigger.
196
197Label the next action correctly: further search, consultation, simulation,
198pilot design, protocol development, preregistration, or no action. If a
199confirmatory study is planned, preregister hypotheses and analysis decisions
200before outcomes are known; report later deviations and exploratory work
201transparently. Preregistration improves transparency but is not peer review,
202ethical approval, or proof of validity.
203
204## Bias and failure controls
205
206- **Production blocking:** private parallel generation before oral discussion.
207- **Anchoring and design fixation:** no leader answer or AI examples until the
208 independent round; reopen generation after evidence review.
209- **Authority and status effects:** leader-last sharing, anonymous input,
210 independent ratings, and visible dissent.
211- **Groupthink:** assign a genuine alternative-generation role, invite outside
212 review, and document rejected options. Treat “groupthink” as a family of
213 risks, not a single universally established diagnosis.
214- **Evaluation apprehension:** separate contribution from attribution where
215 possible; critique ideas, not contributors.
216- **Premature convergence:** fixed divergence window followed by an explicit
217 transition and predeclared criteria.
218- **False precision:** use anchored scales, uncertainty ranges, sensitivity
219 analysis, and narrative review.
220- **Research-gap inflation:** record search boundaries and use “no direct
221 evidence located,” not “never studied.”
222- **AI hallucination or homogenization:** human-first ideation, provenance,
223 independent verification, multiple non-AI perspectives, and comparison for
224 suspiciously repeated frames. See `references/responsible_ai.md`.
225
226## Optional local CLIs
227
228The scripts are deterministic, standard-library utilities. They do not call a
229network service, LLM, or scientific database and do not make scientific
230conclusions.
231
232```bash
233python scripts/session_scaffold.py --help
234python scripts/validate_register.py --help
235python scripts/evaluate_matrix.py --help
236```
237
238Create a session register:
239
240```bash
241python scripts/session_scaffold.py \
242 --session-id "microbiome-01" \
243 --title "Microbiome mechanism ideation" \
244 --question "Which mechanisms could explain the scoped observation?" \
245 --participant P01 --participant P02 \
246 --output session.json
247```
248
249Validate structure and provenance:
250
251```bash
252python scripts/validate_register.py session.json --output validation.json
253```
254
255Calculate a fully disclosed weighted matrix from CSV, including score intervals
256and one-at-a-time weight sensitivity:
257
258```bash
259python scripts/evaluate_matrix.py scores.csv \
260 --config criteria.json \
261 --weight-delta 0.10 \
262 --output matrix.json
263```
264
265Outputs refuse symlinks and existing files unless `--force` is explicit; inputs
266and collection sizes are bounded. The validator checks structure, not truth.
267The matrix preserves qualitative review and uncertainty and leaves
268`decision` null. Input formats and interpretation are documented in
269`references/idea_evaluation.md`.
270
271## Reference index
272
273- `references/brainstorming_methods.md` — evidence-calibrated method selection,
274 nominal groups, Delphi, structured elicitation, and creative prompts.
275- `references/facilitation_workflows.md` — ready-to-run individual, group, and
276 asynchronous session protocols plus provenance templates.
277- `references/idea_evaluation.md` — criteria, scoring formula, uncertainty,
278 sensitivity analysis, gates, and decision logs.
279- `references/responsible_ai.md` — accountable AI assistance, confidentiality,
280 hallucination, homogenization, disclosure, dual-use, and integrity.
281- `references/sources.md` — dated primary studies and official guidance
282 consulted for this version.